Next-Generation Sequencing (NGS) Services Market By End-User (Hospitals And Clinics, Pharmaceutical And Biotechnology Companies), Application (Diagnostics, Drug Discovery & Development), Technology (Sequencing By Synthesis, Nanopore Sequencing), Sequencing Type (Exome Sequencing, Targeted Resequenci

Next-Generation Sequencing (NGS) Services Market Valuation – 2024-2031

The global Next-Generation Sequencing (NGS) Services Market players are developing an advanced perforating gun that achieves greater efficiency in perforation systems and helps to lower the operating costs. The emergence of such perforating guns further fuels the growth of the global perforating guns market. enables the Next-Generation Sequencing (NGS) Services Market Market surpass USD 9.53 Billion valued in 2023 and reach a market revenue of about USD 18.35 Billion by 2031.

The growth of the fossil fuel industry boosts demand for perforating guns to create openings in casings used in oil & gas well drilling. This demand is anticipated to provide effective flow communication among the cased well-bore and a productive reservoir. enabling the market to grow at a CAGR of 21.25% from 2024 to 2031.

Next-Generation Sequencing (NGS) Services MarketDefinition/ Overview

Massively parallel sequencing (MPS), sometimes referred to as next-generation sequencing (NGS), is a term used to characterize a DNA sequencing technology that has greatly benefited the domains of virology, forensic biology, medical diagnosis, biotechnology, and biological systematics. The development of NGS has altered how basic and applied science, as well as clinical research, are conducted. The next-generation sequencing technology makes it possible to sequence the entire human genome much faster than with the older Sanger sequencing technology.

Precision medicine has greatly benefited from the paradigm shift from traditional medicine to next-generation sequencing, which makes it possible to identify biomarkers for early diagnosis and tailored treatments. Even though next-generation sequencing is still relatively new, it has already established itself as a fundamental tool in the fields of genetics and molecular biology, as well as clinical diagnostics, genetic diseases, and personalized medicine.

Which are the Drivers Encouraging the Adoption of Global Next-Generation Sequencing (NGS) Services Market?

The need for NGS services is surging as a result of the ongoing advancements in genomic research, which have greatly increased our understanding of the genetic basis of disease. The need for intricate investigation during genetic variations, detection of disease causing mutations, and identification of personalized treatment plans are propelling the adoption of next-generation sequencing techniques among scientists and medical professionals.

The scaling of economies, sequencing technologies as well as advancements in automation is making sequencing techniques affordable, increasing its application in the coming years. The adoption of NGS services across a variety of applications owing to its low cost, is attracting a larger group of researchers, physicians, and healthcare organizations, enabling the market gain momentum.

Furthermore, the role of NGS in revolutionizing clinical diagnostics it is making it possible to quickly and thoroughly analyze genetic data for diagnostic purposes. The adoption of NGS services in pharmacogenomics, prenatal screening, cancer profiling, and the diagnosis of hereditary diseases is projected to upsurge over the years. Likewise, the growing popularity of personalized treatments is necessitating the use of  NGS services to provide tailored healthcare based on individual genetic profiles. The focus on providing effective therapies based on combination of genomic data and clinical information is a profitable platter for the healthcare professionals  as well as the next-generation sequencing (NGS) services market.

 Will the Complexity of Next-Generation Sequencing (NGS) Services Inhibit its Adoption?

The complexity and cost of NGS technologies and services play a vital role as they require substantial initial investment in equipment, infrastructure, and expertise. This is likely to limit its widespread accessibility and adoption of these advanced sequencing technologies. Likewise, data management and analysis of the massive volume of sequencing data generated by NGS platforms is necessitating robust bioinformatics tools, computational resources, storage solutions, and expertise in data interpretation and analysis, limiting the use of NGS services.

Quality control, standardization, and reproducibility are critical challenges in the NGS services market. Ensuring the accuracy, reliability, and consistency of sequencing results across different platforms, laboratories, and workflows is essential for scientific validity, clinical utility, and regulatory compliance. However, variability in sample preparation, sequencing protocols, data analysis pipelines, and quality metrics is projected to impact the reproducibility of NGS data, leading to challenges in benchmarking, cross-validation, and result validation.

Stringent regulatory and ethical considerations also pose challenges for NGS service providers and users. As compliance with data privacy regulations, patient confidentiality, ethical guidelines, and informed consent requirements is paramount in clinical genomics, genetic testing, and personalized medicine applications, navigating regulatory frameworks, obtaining necessary approvals, ensuring data security, and maintaining ethical standards adds complexity and compliance burdens to NGS service providers and healthcare organizations.

In the healthcare sector, the interpretation and clinical translation of NGS data present challenges, as integrating genomic information into clinical decision-making, disease management, treatment selection, and patient care pathways requires collaboration among geneticists, clinicians, bioinformaticians, and healthcare professionals.

Category-Wise Acumens

How will Popularity of Whole Genome Sequencing Improve Adoption of Next-Generation Sequencing (NGS) Services?

Whole genome sequencing (WGS) is a dominant technology in the next-generation sequencing (NGS) services market due to its comprehensive nature and diverse applications across various sectors. The ability to study genetic variations, mutations, structural changes, and functional elements across the entire genome, providing insights into complex biological processes, disease mechanisms, and personalized medicine applications using WGS is enhancing its application among researchers, clinicians, and organizations.

Also, its role in uncovering novel genetic markers, biomarkers, disease-causing mutations, and therapeutic targets, for advancing our understanding of genetic traits, hereditary diseases, complex disorders, and genetic predispositions will further propel the use of WGS.

In clinical diagnostics and healthcare, WGS plays a crucial role in genetic testing, disease diagnosis, and personalized medicine. Thereby, enabling clinicians to identify disease-causing mutations, assess genetic risk factors, diagnose rare genetic disorders, predict treatment responses, and tailor therapies based on individual genomic profiles. Similarly, WGS is increasingly adopted in agriculture, veterinary medicine, and environmental genomics for applications such as crop improvement, livestock breeding, disease surveillance, biodiversity conservation, and environmental monitoring.

Advancements in sequencing technologies, bioinformatics tools, and data analysis pipelines have reduced the cost, time, and complexity of WGS, making it more accessible and scalable for a wide range of applications and industries. The integration of WGS into clinical workflows, research projects, and large-scale initiatives further solidifies its dominance in the NGS services market.

How Hospitals and Clinics are Influencing the Growth of Next-Generation Sequencing (NGS) Services Market?

Rise in the demand for NGS services in the hospitals and clinics for a variety of clinical diagnostic applications, such as prenatal screening, pharmacogenomics, cancer genomics, rare disease diagnosis, and infectious disease testing is a market profitable factor. With the use of NGS, clinicians can perform The need for thorough genomic profiling of patient samples and detect genetic mutations, structural variants, and biomarkers by the clinicians for offering accurate prognosis, treatment response, and disease risk data is likely to further enhance the growth of the market.

The availability of personalized treatment to cater to the varying needs of the patients in the hospitals and clinics is increasing the incorporation of NGS into standard clinical practice for accurate diagnosis, prognosis, and treatment decisions. Thus, precision programs use next-generation sequencing (NGS) services for genomic testing, risk assessment, and treatment selection for patients with cancer, genetic disorders, and complex medical conditions. These factors help hospitals and clinics maximize treatment outcomes, reduce adverse drug reactions, and enhance patient satisfaction and quality of life by integrating genomic information into clinical decision-making.

Genomic medicine research is carried out extensively in hospitals and academic medical centers with the goal of advancing scientific understanding of genetic diseases, molecular pathways, and therapeutic targets. Through the facilitation of large-scale DNA sequencing, genome-wide association studies (GWAS), and functional genomics experiments, NGS services play a crucial role in supporting genomic research initiatives. In order to conduct translational research projects aimed at developing novel diagnostic tools, targeted therapies, and precision medicine interventions based on genomic insights, hospitals and clinics collaborate with research institutions, biotechnology companies, and pharmaceutical firms.

Gain Access into Global Next-Generation Sequencing (NGS) Services Market Report Methodology

Country/Region-wise Acumens

Which Region is Witnessing Rapid Growth in Next-Generation Sequencing (NGS) Services Market?

One of the most promising areas for the expansion of Next-Generation Sequencing (NGS) services is the Asia-Pacific (APAC) region. Opportunities for investment in cutting-edge genomic technologies like NGS is surging owing to increase in healthcare spending along with the regional economic growth. Similarly, rise in funding for life sciences research and genomic research activities in APAC countries—China, Japan, India, South Korea, and Australia—is likely to enable the market gain momentum in this region.

Growing awareness of personalized healthcare solutions and advances in genomic technologies have fueled the Asia-Pacific region’s adoption of precision medicine approaches in clinical practice. Healthcare professionals in nations like China and Japan are incorporating pharmacogenomics testing, rare disease diagnosis, and routine clinical care for cancer patients with NGS-based genomic testing. The need for NGS services for genomic profiling and treatment optimization is anticipated to increase significantly as precision medicine gains traction.

How is North America in Next-Generation Sequencing (NGS) Services Market?

The market for Next-Generation Sequencing (NGS) services is dominated by North America. With its advanced healthcare facilities, academic medical centers, research institutions, and biotechnology companies, North America has a well-established healthcare infrastructure. As the region has a strong healthcare ecosystem, the application of modern genomic technologies like NGS and integration into clinical practice and research endeavors is gaining popularity.

With the primary focus on technological innovation in genomics and molecular diagnostics, North America is likely to hold a leading position on the global platform. Also, the presence of leading producers of sequencing platforms, NGS technology developers, and bioinformatics solution providers in this region will further drive the market. Constant R&D expenditures propel the creation of novel sequencing platforms, enhanced processes, and creative uses for NGS technology, establishing North America as a center for NGS innovation and commercialization. When it comes to using NGS services for a variety of purposes, such as clinical diagnostics, precision medicine, and research, North America leads the world in this regard. Large-scale genomic research projects being worked on in the academic and research institutions in the US and Canada with the goal of comprehending the biology of disease, finding genetic variants linked to complex diseases, and creating targeted treatments is enabling the market grow in North America.

Competitive Landscape

The next-generation sequencing (NGS) services market is characterized by intense competition among various players offering sequencing services, platforms, software solutions, and bioinformatics services. Key players include established NGS service providers, genomics companies, academic institutions, contract research organizations, and healthcare organizations. The competitive environment is shaped by factors such as technological advancements, service quality, pricing strategies, geographic reach, regulatory compliance, research collaborations, and strategic partnerships. As demand for genomic sequencing services rises in research, clinical diagnostics, pharmaceuticals, and agriculture, competition is expected to intensify, driving innovation and market expansion. Understanding the competitive landscape is crucial for stakeholders to identify growth opportunities and stay competitive in this rapidly evolving market segment.

Some of the prominent players operating in the Next-Generation Sequencing (NGS) Services Market include

• Quest Diagnostics Incorporated
• ARUP Laboratories
• Applied Biological Materials, Inc. (abm)
• Novogene Co, Ltd.
• Azenta Life Sciences (GENEWIZ)
• NanoString
• Illumina, Inc.
• PacBio
• Veritas
• BGI (Beijing Genomics Institute)
• Gene by Gene Ltd.
• Lucigen Corporation

Latest Developments

• In January 2023, QIAGEN announced a strategic partnership with California-based population genomics leader Helix to advance next-generation sequencing companion diagnostics in hereditary diseases.
• In March 2023, The Company SOPHiA GENETICS announced a new partnership with Qiagen that will pair QIAseq reagent technology with the DDM platform to enhance tumor analysis through next-generation sequencing (NGS).
• In September 2022, Illumina Inc. launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus), new production-scale next-generation sequencers that will enable faster, more powerful, and more sustainable sequencing.
• In March 2022, Thermo Fisher Scientific launched the CE-IVD-marked Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform that delivers results in as little as a single day.

Report Scope

Next-Generation Sequencing (NGS) Services Market, By Category

End-User

• Hospitals and Clinics
• Contract Research Organizations (CROs)
• Academic & Research Institution
• Pharmaceutical and Biotechnology Companies

Application

• Diagnostics
• Drug Discovery & Development
• Oncology
• Agriculture & Animal Research
• Functional Genomics
• Others

Technology

• Sequencing by Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-time Sequencing

 Service Type

• Exome Sequencing
• Targeted sequencing
• Custom Gene Panels
• Whole Genome Sequencing
• De Novo Sequencing
• RNA-Seq
• CHiP-Seq
• Methyl-Seq
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.